Tvardi Therapeutics, Inc. (TVRD)

Tvardi Therapeutics Statistics

Total Valuation

TVRD has a market cap or net worth of $37.81 million. The enterprise value is $1.57 million.

Market Cap	37.81M
Enterprise Value	1.57M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TVRD has 9.38 million shares outstanding. The number of shares has increased by 170.52% in one year.

Current Share Class	9.38M
Shares Outstanding	9.38M
Shares Change (YoY)	+170.52%
Shares Change (QoQ)	+10.90%
Owned by Insiders (%)	18.52%
Owned by Institutions (%)	32.12%
Float	6.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.36
P/TBV Ratio	1.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.48, with a Debt / Equity ratio of 0.01.

Current Ratio	3.48
Quick Ratio	3.30
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -135.64% and return on invested capital (ROIC) is -105.82%.

Return on Equity (ROE)	-135.64%
Return on Assets (ROA)	-72.68%
Return on Invested Capital (ROIC)	-105.82%
Return on Capital Employed (ROCE)	-107.08%
Revenue Per Employee	n/a
Profits Per Employee	-$1.97M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -65.46% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-65.46%
50-Day Moving Average	21.09
200-Day Moving Average	21.79
Relative Strength Index (RSI)	19.44
Average Volume (20 Days)	279,834

Short Selling Information

The latest short interest is 1.02 million, so 10.92% of the outstanding shares have been sold short.

Short Interest	1.02M
Short Previous Month	1.18M
Short % of Shares Out	10.92%
Short % of Float	16.78%
Short Ratio (days to cover)	0.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-29.96M
Pretax Income	-23.65M
Net Income	-23.65M
EBITDA	-29.87M
EBIT	-29.96M
Earnings Per Share (EPS)	-$3.23

Balance Sheet

The company has $36.46 million in cash and $228,000 in debt, giving a net cash position of $36.23 million or $3.86 per share.

Cash & Cash Equivalents	36.46M
Total Debt	228,000
Net Cash	36.23M
Net Cash Per Share	$3.86
Equity (Book Value)	27.87M
Book Value Per Share	2.97
Working Capital	27.40M

Cash Flow

Operating Cash Flow	-22.65M
Capital Expenditures	n/a
Free Cash Flow	-22.65M
FCF Per Share	-$2.41

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TVRD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-170.52%
Shareholder Yield	-170.52%
Earnings Yield	-62.54%
FCF Yield	-59.90%

Analyst Forecast

The average price target for TVRD is $51.67, which is 1,182.13% higher than the current price. The consensus rating is "Buy".

Price Target	$51.67
Price Target Difference	1,182.13%
Analyst Consensus	Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-1.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2